drugset / Trial / NCT00714337

Formulation and Food Effect Study of AZD1386 in Healthy Volunteers

NCT00714337

Phase 1 Completed 12 enrolled AstraZeneca
RandomizedCrossoverOpen-labelBasic science

Summary

To investigate the pharmacokinetics of two oral solid formulations of AZD1386 in relation to the AZD1386 oral solution.

Timeline

Start
2008-06
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD1386 Small molecule 90 mg Oral

Indications

No indication recorded.